publication venue for
- Leptomeningeal dissemination in pediatric brain tumors.. 39. 2023
- The children's brain tumor network (CBTN) - Accelerating research in pediatric central nervous system tumors through collaboration and open science.. 35. 2022
- Telomere Trimming and DNA Damage as Signatures of High Risk Neuroblastoma.. 21. 2019
- Characterization of the ERG-regulated Kinome in Prostate Cancer Identifies TNIK as a Potential Therapeutic Target.. 21. 2019
- Current Treatment of Bilateral Retinoblastoma: The Impact of Intraarterial and Intravitreous Chemotherapy.. 20. 2018
- Matrix Metalloproteinase 14 promotes lung cancer by cleavage of Heparin-Binding EGF-like Growth Factor.. 19. 2016
- Corrigendum to "Noninvasive Multimodality Imaging of the Tumor Microenvironment: Registered Dynamic Magnetic Resonance Imaging and Positron Emission Tomography Studies of a Preclinical Tumor Model of Tumor Hypoxia" [Neoplasia 11 (2009) 247-259].. 18. 2016
- Patient-Specific Screening Using High-Grade Glioma Explants to Determine Potential Radiosensitization by a TGF-β Small Molecule Inhibitor.. 18. 2016
- p53 and p16Ink4a/p19Arf Loss Promotes Different Pancreatic Tumor Types from PyMT-Expressing Progenitor Cells.. 18. 2016
- Metabolic plasticity of metastatic breast cancer cells: adaptation to changes in the microenvironment.. 17. 2015
- Molecular subtypes of uterine leiomyosarcoma and correlation with clinical outcome.. 17. 2015
- SPOP mutations in prostate cancer across demographically diverse patient cohorts.. 16. 2014
- Identification of molecular tumor markers in renal cell carcinomas with TFE3 protein expression by RNA sequencing.. 15. 2013
- Combination of the PI3K inhibitor ZSTK474 with a PSMA-targeted immunotoxin accelerates apoptosis and regression of prostate cancer.. 15. 2013
- Cross modulation between the androgen receptor axis and protocadherin-PC in mediating neuroendocrine transdifferentiation and therapeutic resistance of prostate cancer.. 15. 2013
- The IL-6/JAK/Stat3 feed-forward loop drives tumorigenesis and metastasis.. 15. 2013
- Epigenomic alterations in localized and advanced prostate cancer.. 15. 2013
- Concurrent AURKA and MYCN gene amplifications are harbingers of lethal treatment-related neuroendocrine prostate cancer.. 15. 2013
- Fluorine-labeled dasatinib nanoformulations as targeted molecular imaging probes in a PDGFB-driven murine glioblastoma model.. 14. 2012
- Stromal cell-derived factor 1α mediates resistance to mTOR-directed therapy in pancreatic cancer.. 14. 2012
- ERG cooperates with androgen receptor in regulating trefoil factor 3 in prostate cancer disease progression.. 12. 2010
- Pharmacodynamic characterization of the efficacy signals due to selective BRAF inhibition with PLX4032 in malignant melanoma.. 12. 2010
- SCCRO promotes glioma formation and malignant progression in mice.. 12. 2010
- N-myc downstream regulated gene 1 (NDRG1) is fused to ERG in prostate cancer.. 11. 2009
- Tumor-selective response to antibody-mediated targeting of alphavbeta3 integrin in ovarian cancer.. 10. 2008
- Integrated nanosensors to determine levels and functional activity of human telomerase.. 10. 2008
- Utility of a herpes oncolytic virus for the detection of neural invasion by cancer.. 10. 2008
- EML4-ALK fusion lung cancer: a rare acquired event.. 10. 2008
- FK506 binding protein mediates glioma cell growth and sensitivity to rapamycin treatment by regulating NF-kappaB signaling pathway.. 10. 2008
- Validation of dynamic contrast-enhanced magnetic resonance imaging-derived vascular permeability measurements using quantitative autoradiography in the RG2 rat brain tumor model.. 9. 2007
- Endothelin receptor A blockade enhances taxane effects in prostate cancer.. 8. 2006
- Combined analysis of COX-2 and p53 expressions reveals synergistic inverse correlations with microsatellite instability and CpG island methylator phenotype in colorectal cancer.. 8. 2006
- The characteristics of astrocytomas and oligodendrogliomas are caused by two distinct and interchangeable signaling formats.. 7. 2005
- mTOR promotes survival and astrocytic characteristics induced by Pten/AKT signaling in glioblastoma.. 7. 2005
- Clinical implications of promoter hypermethylation in RASSF1A and MGMT in retinoblastoma.. 7. 2005
- Characteristics of stem cells from human neuroblastoma cell lines and in tumors.. 6. 2004
- Cytoplasmically retargeted HSV1-tk/GFP reporter gene mutants for optimization of noninvasive molecular-genetic imaging.. 5. 2003
- Antitumor activity and prolonged expression from a TRAIL-expressing adenoviral vector.. 4. 2002
- MRI of mouse models for gliomas shows similarities to humans and can be used to identify mice for preclinical trials.. 4. 2002
- Imaging TCR-dependent NFAT-mediated T-cell activation with positron emission tomography in vivo.. 3. 2001
- Using positron emission tomography with [(18)F]FDG to predict tumor behavior in experimental colorectal cancer.. 3. 2001
- A general approach to the non-invasive imaging of transgenes using cis-linked herpes simplex virus thymidine kinase.. 1. 1999
- Cancer patient T cells genetically targeted to prostate-specific membrane antigen specifically lyse prostate cancer cells and release cytokines in response to prostate-specific membrane antigen.. 1. 1999
- Functional coexpression of HSV-1 thymidine kinase and green fluorescent protein: implications for noninvasive imaging of transgene expression.. 1. 1999
- Applications of magnetic resonance in model systems: cancer therapeutics. 2000
- Imaging transgene expression with radionuclide imaging technologies. 2000